Page last updated: 2024-08-17

cysteamine and Bone Diseases

cysteamine has been researched along with Bone Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bacchetta, J; Bertholet-Thomas, A; Carlier, MC; Claramunt-Taberner, D; Cochat, P; Cohen-Solal, M; DeschĂȘnes, G; Gaillard, S; Pelletier, S; Sornay-Rendu, E; Szulc, P1
Ariceta, G; Awan, A; Bacchetta, J; Bechtold, S; Bergmann, C; Cassidy, N; Deschenes, G; Elenberg, E; Gahl, WA; Greil, O; Haffner, D; Harms, E; Herzig, N; Hohenfellner, K; Hoppe, B; Koeppl, C; Levtchenko, E; Lewis, MA; Nesterova, G; Rauch, F; Santos, F; Schlingmann, KP; Servais, A; Soliman, NA; Steidle, G; Sweeney, C; Topaloglu, R; Treikauskas, U; Tsygin, A; V Vigier, R; Veys, K; Zustin, J1
Aina, V; Cerrato, G; Lusvardi, G; Magistris, C; Malavasi, G; Martra, G; Menabue, L; Viscardi, G1
LETIZIA, G; PATANIA, S1

Trials

1 trial(s) available for cysteamine and Bone Diseases

ArticleYear
Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairment.
    Pediatric nephrology (Berlin, Germany), 2018, Volume: 33, Issue:7

    Topics: Absorptiometry, Photon; Adolescent; Adult; Age Factors; Biomarkers; Bone Density; Bone Diseases; Child; Cortical Bone; Cysteamine; Cystinosis; Female; Fibroblast Growth Factor-23; Humans; Male; Pilot Projects; Prevalence; Prospective Studies; Quality of Life; Radius; Severity of Illness Index; Tibia; Tomography, X-Ray Computed; Young Adult

2018

Other Studies

3 other study(ies) available for cysteamine and Bone Diseases

ArticleYear
Management of bone disease in cystinosis: Statement from an international conference.
    Journal of inherited metabolic disease, 2019, Volume: 42, Issue:5

    Topics: Administration, Oral; Bone Diseases; Cysteamine; Cystinosis; Disease Management; Fanconi Syndrome; Female; Humans; Male

2019
New formulation of functionalized bioactive glasses to be used as carriers for the development of pH-stimuli responsive biomaterials for bone diseases.
    Langmuir : the ACS journal of surfaces and colloids, 2014, Apr-29, Volume: 30, Issue:16

    Topics: Animals; Biocompatible Materials; Bone Diseases; Cysteamine; Drug Delivery Systems; Fluoresceins; Glass; Humans; Hydrogen-Ion Concentration

2014
[Action of beta-mercaptoethylamine on the reparative process in experimental bone lesions].
    Sicilia sanitaria, 1961, Volume: 14

    Topics: Animals; Bone Diseases; Cartilage Diseases; Cysteamine; Fractures, Bone; Mercaptoethylamines

1961